Inimmune

Inimmune is a promising new biotechnology company founded by veterans of the pharmaceutical industry, dedicated to developing the next generation of vaccines and immunotherapies. The team has extensive expertise in synthetic and process chemistry, drug formulation, and immunology. Inimmune's pipeline includes innovative new therapies aimed at harnessing the innate immune system in key areas of patient need such as cancer, allergic rhinitis, food allergies, infectious disease vaccines, and novel antibiotics for bacterial infections.